LIfT BioSciences Secures €12M Grant for IMAN Cancer Immunotherapy Trials

Cancer, a disease that has long challenged medical science, often finds ways to evade even the most advanced treatments, leading to what is known as "treatment resistance". This resistance is a major hurdle, responsible for the vast majority—over 90%—of cancer-related deaths.